News for Lotus Pharmaceutical Co., Ltd. (1795.TW)

Exclusive agreement includes up to $125 million in upfront and milestone payments to LENZ together with double-digit royalties on future net sales SAN DIEGO a

SAN DIEGO and TAIPEI, Taiwan, May 09, 2025 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ) and Lotus Pharmaceutical Co., Ltd. (“Lotus...

TAIPEI, July 11, 2024 /PRNewswire/ -- HR Asia, the leading publication in the human resources industry, announces the winners of its prestigious HR Asia Best Companies to Work for in Asia 2024 - Taiwan awards. This year, a total of 92 outstanding companies have been recognized for their exemplary HR practices, showcasing their commitment to fostering a vibrant and diverse workplace environment.

NRx Pharmaceuticals receives a $5 million milestone payment

/PRNewswire/ -- The "Active Pharmaceutical Ingredients (API) Global Market - Forecast To 2029" & "Pharmaceutical Excipients Global Market - Forecast To 2029"...

21 September 2022, 7:30 CEST - Taipei City, Taiwan and Liege, Belgium - Lotus Pharmaceutical Co., Ltd. and Mithra Pharmaceuticals, SA today are pleased to announce that Estelle®, the... | September 21, 2022

Innobic (Asia) Co., Ltd., a wholly-owned subsidiary and life science arm of the national oil and gas conglomerate PTT, together with Aztiq HK Ltd., is acting on its promise to uplift Thailand’s life science business by completing a deal to buy out Alvogen Emerging Markets Holdings Ltd. (AEMH), raising Innobic’s shareholding in Taiwan-based Lotus Pharmaceutical Co., Ltd. to 37% from 6.6%.

Close Today's Information ... | January 28, 2022

Read more about Glenmark Pharma inks exclusive licensing agreement with Lotus International on Business Standard. Glenmark Pharmaceuticals Ltd on Thursday said its Swiss arm has entered into an exclusive licensing agreement with Lotus International Pte Ltd

Under the agreement signed between Glenmark Specialty SA and the wholly-owned subsidiary of Lotus Pharmaceutical Co, Ltd (Lotus), Glenmark will be responsible for manufacturing and supply of Ryaltris.